New York Medscan Inc is categorized under Position Emission Tomography (Pet Scanner) in New York City, NY and active since 2008.
New York Medscan Inc was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Position Emission Tomography (Pet Scanner) business, which does work in the B2B market, and is classified as a Position Emission Tomography (Pet Scanner), under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Harry Greenbaum at the company’s single location by writing to 751 2nd Avenue, New York City, New York NY 10017 or by phoning (212) 682-4066. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | New York Medscan Inc |
| Contact Person: | Harry Greenbaum |
| Address: | 751 2nd Avenue, New York City, New York 10017 |
| Phone Number: | (212) 682-4066 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Position Emission Tomography (Pet Scanner) |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
New York Medscan Inc was started in 2008 to provide professional Position Emission Tomography (Pet Scanner) under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Harry Greenbaum for inquiries that concern New York Medscan Inc by calling the company number (212) 682-4066, as your correspondence is most welcome. Additionally, the physical location of the single location of New York Medscan Inc can be found at the coordinates 40.748821,-73.973142 as well as the street address 751 2nd Avenue in New York City, New York 10017.
For its online presence, you may visit New York Medscan Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.